Ceralasertib

Ceralasertib is an investigational new drug that is being evaluated for the treatment of cancer.^[1] It is an ATR kinase inhibitor.^[2]

Ceralasertib

Clinical data
Other names	AZD-6738
Legal status
Legal status	Investigational
Identifiers
IUPAC name imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane
CAS Number	1352226-88-0
PubChem CID	54761306
IUPHAR/BPS	9390
DrugBank	DB14917
ChemSpider	58828171
UNII	85RE35306Z
KEGG	D11787
ChEMBL	ChEMBL4285417
PDB ligand	VJM (PDBe, RCSB PDB)
ECHA InfoCard	100.232.607
Chemical and physical data
Formula	C20H24N6O2S
Molar mass	412.51 g·mol−1
3D model (JSmol)	Interactive image
SMILES C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4
InChI InChI=1S/C20H24N6O2S/c1-13-12-28-10-9-26(13)17-11-16(20(5-6-20)29(2,21)27)24-19(25-17)15-4-8-23-18-14(15)3-7-22-18/h3-4,7-8,11,13,21H,5-6,9-10,12H2,1-2H3,(H,22,23)/t13-,29-/m1/s1 Key:OHUHVTCQTUDPIJ-JYCIKRDWSA-N